Folgen
Mohammad Mashreghi
Mohammad Mashreghi
PhD in Pharmaceutical Nanotechnology, Mashhad University of Medical Sciences
Bestätigte E-Mail-Adresse bei mums.ac.ir
Titel
Zitiert von
Zitiert von
Jahr
Biosynthesis of selenium nanoparticles using Enterococcus faecalis and evaluation of their antibacterial activities
S Shoeibi, M Mashreghi
Journal of Trace Elements in Medicine and Biology 39, 135-139, 2017
1862017
Angiogenesis biomarkers and their targeting ligands as potential targets for tumor angiogenesis
M Mashreghi, H Azarpara, MR Bazaz, A Jafari, A Masoudifar, H Mirzaei, ...
Journal of cellular physiology 233 (4), 2949-2965, 2018
1292018
Silver-zinc oxide nanocomposite: From synthesis to antimicrobial and anticancer properties
SM Mousavi-Kouhi, A Beyk-Khormizi, MS Amiri, M Mashreghi, MET Yazdi
Ceramics International 47 (15), 21490-21497, 2021
872021
Development of chitosan-coated liposome for pulmonary delivery of N-acetylcysteine
H Hamedinasab, AH Rezayan, M Mellat, M Mashreghi, MR Jaafari
International journal of biological macromolecules 156, 1455-1463, 2020
812020
A study on the role of cholesterol and phosphatidylcholine in various features of liposomal doxorubicin: From liposomal preparation to therapy
H Farzaneh, ME Nik, M Mashreghi, Z Saberi, MR Jaafari, M Teymouri
International journal of pharmaceutics 551 (1-2), 300-308, 2018
772018
Redox-sensitive nanoscale drug delivery systems for cancer treatment
E Mirhadi, M Mashreghi, MF Maleki, SH Alavizadeh, L Arabi, A Badiee, ...
International journal of pharmaceutics 589, 119882, 2020
762020
Green Synthesis of Silver Nanoparticles Using Helichrysum graveolens for Biomedical Applications and Wastewater Treatment
ME Taghavizadeh Yazdi, MS Amiri, S Akbari, M Sharifalhoseini, ...
BioNanoScience 10, 1121-1127, 2020
632020
Anti-Epcam aptamer (Syl3c)-functionalized liposome for targeted delivery of doxorubicin: In vitro and in vivo antitumor studies in mice bearing C26 colon carcinoma
M Mashreghi, P Zamani, SA Moosavian, MR Jaafari
Nanoscale Research Letters 15, 1-13, 2020
572020
Preparation and characterization of stable nanoliposomal formulations of curcumin with high loading efficacy: in vitro and in vivo anti-tumor study
M Karimi, F Gheybi, P Zamani, M Mashreghi, S Golmohammadzadeh, ...
International journal of pharmaceutics 580, 119211, 2020
512020
Antimycobacterial, Anticancer, Antioxidant and Photocatalytic Activity of Biosynthesized Silver Nanoparticles Using Berberis Integerrima
ME Taghavizadeh Yazdi, M Darroudi, MS Amiri, H Zarrinfar, HA Hosseini, ...
Iranian Journal of Science and Technology, Transactions A: Science, 1-11, 2022
502022
Folate targeted PEGylated liposomes for the oral delivery of insulin: In vitro and in vivo studies
JR Yazdi, M Tafaghodi, K Sadri, M Mashreghi, AR Nikpoor, ...
Colloids and Surfaces B: Biointerfaces 194, 111203, 2020
482020
Ultrasound-based synthesis of ZnO·Ag2O3 nanocomposite: characterization and evaluation of its antimicrobial and anticancer properties
ME Taghavizadeh Yazdi, F Nourbakhsh, M Mashreghi, SH Mousavi
Research on Chemical Intermediates 47, 1285-1296, 2021
472021
Biological synthesis and characterization of gold nanoparticles using Verbascum speciosum Schrad. and cytotoxicity properties toward HepG2 cancer cell line
SM Mousavi-Kouhi, A Beyk-Khormizi, V Mohammadzadeh, M Ashna, ...
Research on Chemical Intermediates, 1-12, 2022
442022
Anticancer, antimicrobial, and dye degradation activity of biosynthesised silver nanoparticle using Artemisia kopetdaghensis
ME Taghavizadeh Yazdi, M Darroudi, MS Amiri, HA Hosseini, ...
Micro & Nano Letters 15 (14), 1046-1050, 2020
432020
Topical effects of frog “Rana ridibunda” skin secretions on wound healing and reduction of wound microbial load
M Mashreghi, MR Bazaz, NM Shahri, A Asoodeh, M Mashreghi, ...
Journal of ethnopharmacology 145 (3), 793-797, 2013
392013
Resveratrol-mediated gold-nanoceria synthesis as green nanomedicine for phytotherapy of hepatocellular carcinoma
G Adel, M Javad, MS Amiri, M Mohammad, H Alireza, H Aliakbar, ...
Frontiers in Bioscience 27 (8), 1-6, 2022
372022
Endogenous stimuli-responsive linkers in nanoliposomal systems for cancer drug targeting
MF Maleki, A Jafari, E Mirhadi, A Askarizadeh, B Golichenari, ...
International journal of pharmaceutics 572, 118716, 2019
332019
Combination therapy with liposomal doxorubicin and liposomal vaccine containing E75, an HER-2/neu-derived peptide, reduces myeloid-derived suppressor cells and improved tumor …
P Zamani, JG Navashenaq, M Teymouri, M Karimi, M Mashreghi, ...
Life sciences 252, 117646, 2020
322020
Preparation and characterization of nanoliposomal bortezomib formulations and evaluation of their anti-cancer efficacy in mice bearing C26 colon carcinoma and B16F0 melanoma
M Korani, S Ghaffari, H Attar, M Mashreghi, MR Jaafari
Nanomedicine: nanotechnology, biology and medicine 20, 102013, 2019
302019
Improving anti-tumour efficacy of PEGylated liposomal doxorubicin by dual targeting of tumour cells and tumour endothelial cells using anti-p32 CGKRK peptide
M Mashreghi, M Faal Maleki, M Karimi, F Kalalinia, A Badiee, MR Jaafari
Journal of drug targeting 29 (6), 617-630, 2021
282021
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20